Diabetes technology & therapeutics
-
Diabetes Technol. Ther. · Jun 2010
Randomized Controlled Trial Clinical TrialA diabetes-specific enteral formula improves glycemic variability in patients with type 2 diabetes.
Well-controlled studies have demonstrated that inpatient hyperglycemia is an indicator of poor clinical outcomes, but the use of diabetes-specific enteral formulas in hospitalized patients remains a topic of great debate. ⋯ Relative to the standard formula, the diabetes-specific formula reduced postprandial glycemia, mean glucose, glycemic variability, and short-acting insulin requirements. These results suggest potential clinical usefulness of a diabetes-specific enteral formula for minimizing glycemic excursions in hospitalized patients.